Search Thermo Fisher Scientific
LC-MS Innovation Summit 2021
Virtual Event
Shaping the Future of LC-MS in Life Science Together
The global pandemic has not only changed our plans for how we live and work, but also accelerated the need for innovation to protect human health. Our LC-MS Innovation Summit presents firsthand perspectives from Life Science Changemakers who are transforming the future of human health.
This on-demand content takes an outside-in look at key life sciences trends. Learn how the latest Thermo Fisher Scientific technology advances are helping to shape the future of LC-MS in the Life Sciences together with thought leaders and innovators.
New products launched
Orbitrap IQ-X Tribrid mass spectrometer
Designed for small-molecule analysis
The Thermo Scientific Orbitrap IQ-X Tribrid mass spectrometer lets you capture more low-abundance analytes in complex samples for both in-structure elucidation and on-the-fly identification of small molecules. To integrate independent experiments into a single automated workflow the novel Thermo Scientific AcquireX automated data acquisition technology enhances real-time, selective LC-MSn data acquisition.
Combined with optional differential ion mobility with the Thermo Scientific FAIMS Pro Duo interface and Tribrid MS provides the unrivaled solution for intelligent MSn analysis of small molecules.
FAIMS Pro Duo Interface for Mass Spectrometry
Maximum usability and selectivity for a broad range of mass spectrometry workflows
The Thermo Scientific FAIMS Pro Duo interface extends differential ion mobility to address analytical challenges for a broad range of qualitative and quantitative applications. Increase signal-to-noise ratios, sample throughput, and coverage for large- and small-molecule LC-MSn methods. Enhanced method optimization lets you easily integrate orthogonal selectivity into existing workflows
Keynotes and Presentations
General Session
| |
|---|---|
| Dr. Iain Mylchreest, Thermo Fisher Scientific | |
Pharma & Biopharma
| |
| Prof. Jonathan Bones, NIBRT | |
| Prof. Mark Dickman, Engineering University of Sheffield | |
| Reiko Kiyonami, Thermo Fisher Scientific | |
| Christopher Crittenden, Ph.D., Genentech | |
| Scott Stanley, Ph.D., University of Kentucky | |
| Benjamin T. Walters, Genentech | |
Life Science Omics Research
| |
Proteomics & Structural Biology
| |
| Henning Urlaub, University Medical Center Göttingen | |
| Martin Frejno, Managing Director | |
| Kristin Burnum-Johnson, Pacific Northwest National Laboratory | |
Metabolomics & Lipidolomics
| |
| Joshua Coon, Ph.D., University of Wisconsin, Madison | |
| Gary Patti, Ph.D., Washington University St. Louis | |
| Amanda Souza, Thermo Fisher Scientific | |
Clinical Research and Toxicology
| |
| Bill Clarke, Ph.D, MBA, DABCC, Johns Hopkins University School of Medicine | |
| Joel Braunstein, MD, MBA, C2N Diagnostics | |
| Livia Eberlin, Ph.D., The University of Texas at Austin, Department of Surgery, Baylor College of Medicine | |
| Kevin Rosenblatt, MD, Ph.D., NX PreNatal | |
| Screening and Semi-quantitation of 212 Fentanyl Analog Compounds | Stephanie Samra, Thermo Fisher Scientific |
| Simon Hudson, LGC | |
New products launched
Orbitrap IQ-X Tribrid mass spectrometer
Designed for small-molecule analysis
The Thermo Scientific Orbitrap IQ-X Tribrid mass spectrometer lets you capture more low-abundance analytes in complex samples for both in-structure elucidation and on-the-fly identification of small molecules. To integrate independent experiments into a single automated workflow the novel Thermo Scientific AcquireX automated data acquisition technology enhances real-time, selective LC-MSn data acquisition.
Combined with optional differential ion mobility with the Thermo Scientific FAIMS Pro Duo interface and Tribrid MS provides the unrivaled solution for intelligent MSn analysis of small molecules.
FAIMS Pro Duo Interface for Mass Spectrometry
Maximum usability and selectivity for a broad range of mass spectrometry workflows
The Thermo Scientific FAIMS Pro Duo interface extends differential ion mobility to address analytical challenges for a broad range of qualitative and quantitative applications. Increase signal-to-noise ratios, sample throughput, and coverage for large- and small-molecule LC-MSn methods. Enhanced method optimization lets you easily integrate orthogonal selectivity into existing workflows
Keynotes and Presentations
General Session
| |
|---|---|
| Dr. Iain Mylchreest, Thermo Fisher Scientific | |
Pharma & Biopharma
| |
| Prof. Jonathan Bones, NIBRT | |
| Prof. Mark Dickman, Engineering University of Sheffield | |
| Reiko Kiyonami, Thermo Fisher Scientific | |
| Christopher Crittenden, Ph.D., Genentech | |
| Scott Stanley, Ph.D., University of Kentucky | |
| Benjamin T. Walters, Genentech | |
Life Science Omics Research
| |
Proteomics & Structural Biology
| |
| Henning Urlaub, University Medical Center Göttingen | |
| Martin Frejno, Managing Director | |
| Kristin Burnum-Johnson, Pacific Northwest National Laboratory | |
Metabolomics & Lipidolomics
| |
| Joshua Coon, Ph.D., University of Wisconsin, Madison | |
| Gary Patti, Ph.D., Washington University St. Louis | |
| Amanda Souza, Thermo Fisher Scientific | |
Clinical Research and Toxicology
| |
| Bill Clarke, Ph.D, MBA, DABCC, Johns Hopkins University School of Medicine | |
| Joel Braunstein, MD, MBA, C2N Diagnostics | |
| Livia Eberlin, Ph.D., The University of Texas at Austin, Department of Surgery, Baylor College of Medicine | |
| Kevin Rosenblatt, MD, Ph.D., NX PreNatal | |
| Screening and Semi-quantitation of 212 Fentanyl Analog Compounds | Stephanie Samra, Thermo Fisher Scientific |
| Simon Hudson, LGC | |